Skip to main content
Clinical Trials/NL-OMON48979
NL-OMON48979CompletedNot Applicable

Study on Transfusion Effects in Preterm infants - STEP-trial

niversitair Medisch Centrum Groningen0 sites67 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
67

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
2 to 11 (—)

Inclusion Criteria

  • - gestational age < 32 weeks
  • - before 7 days of age
  • - written informed consent by legal representative(s)

Exclusion Criteria

  • - Chromosomal abnormality (e.g. trisomy 13, 18, 21)
  • - Perinatal asphyxia resulting in Apgar score (AS) < 5 at five minutes
  • - Major congenital malformations that increase the risk of death or adverse
  • neurodevelopmental outcome (congenital cerebral malformations, congenital heart
  • diseases excluding patent ductus arteriosus)
  • - Intraventricular and periventricular hemorrhage > grade 2 according to
  • Papile, prior to inclusion
  • - Diagnosis of NEC prior to inclusion
  • - Alloimmune hemolytic disease, sickle-cell disease or thalassemia
  • - Any received RBC transfusions prior to inclusion
  • - Inability to understand Dutch by the parents
  • - Parents expressing strong philosophical or religious objections to
  • transfusion

Investigators

Similar Trials

Study on Transfusion Effects in Preterm... | Clinical Trial